1. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010 age-period-cohort analysis.
BMJ 347:f65642013;
2. Saleem S, McClure EM, Goudar SS, et al. A prospective study of maternal, fetal and neonatal deaths in low- and middle-income countries.
Bull World Health Organ 1:605–612. 2014;
3. Souza JP, Gülmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study.
Lancet 381:1747–1755. 2013;
4. Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia.
J Pediatr 156:532–536. 2010;
5. Strand KM, Heimstad R, Iversen AC, et al. Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study.
BMJ 347:f40892013;
6. Prakash J, Ganiger VC, Prakash S, et al. Acute kidney injury in pregnancy with special reference to pregnancy-specific disorders: a hospital based study 2014–2016.
J Nephrol 31:79–85. 2018;
7. Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.
Clin J Am Soc Nephrol 10:147–155. 2015;
8. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury.
Annu Rev Pharmacol Toxicol 48:463–493. 2008;
9. Jim B, Garovic VD. Acute kidney injury in pregnancy.
Semin Nephrol 37:378–385. 2017;
10. Kreepala C, Luangphiphat W, Villarroel A, Kitporntheranunt M, Wattanavaekin K, Piyajarawong T. Effect of magnesium on glomerular filtration rate and recovery of hypertension in women with severe preeclampsia.
Nephron 138:35–41. 2018;
11. Kreepala C, Kitporntheranunt M, Sangwipasnapaporn W, Rungsrithananon W, Wattanavaekin K. Assessment of pre-eclampsia risk by use of serum ionized magnesium-based equation.
Ren Fail 40:99–106. 2018;
12. Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy.
Kidney Int 54:2056–2063. 1998;
13. Huang C, Chen S. Acute kidney injury during pregnancy and puerperium: a retrospective study in a single center.
BMC Nephrol 18:1462017;
14. Smith MC, Moran P, Ward MK, Davison JM. Assessment of glomerular filtration rate during pregnancy using the MDRD formula.
BJOG 115:109–112. 2008;
15. Siew ED, Ware LB, Ikizler TA. Biological markers of acute kidney injury.
J Am Soc Nephrol 22:810–820. 2011;
16. Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A. Cystatin C as a marker of GFR—history, indications, and future research.
Clin Biochem 38:1–8. 2005;
17. Roos JF, Doust J, Tett SE, Kirkpatrick CM. Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis.
Clin Biochem 40:383–391. 2007;
18. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.
Am J Kidney Dis 40:221–226. 2002;
19. Zappitelli M, Greenberg JH, Coca SG, et al. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery.
JAMA Pediatr 169:583–591. 2015;
20. Yalcin S, Ulas T, Eren MA, et al. Relationship between oxidative stress parameters and cystatin C levels in patients with severe preeclampsia.
Medicina (Kaunas) 49:118–123. 2013;
21. Niraula A, Lamsal M, Baral N, et al. Cystatin-C as a marker for renal impairment in preeclampsia.
J Biomark 2017:7406959. 2017
22. Abitbol CL, Seeherunvong W, Galarza MG, et al. Neonatal kidney size and function in preterm infants: what is a true estimate of glomerular filtration rate?
J Pediatr 164:1026–1031. 2014;
23. Gursoy AY, Tasci Y, Celik H, et al. The prognostic value of first-trimester cystatin C levels for gestational complications.
J Perinat Med 44:295–299. 2016;
24. Risch M, Purde MT, Baumann M, et al. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies.
Scand J Clin Lab Invest 77:634–643. 2017;
25. Buderer NM. Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity.
Acad Emerg Med 3:895–900. 1996;
26. Ngwenya S. Severe preeclampsia and eclampsia: incidence, complications, and perinatal outcomes at a low-resource setting, Mpilo Central Hospital, Bulawayo, Zimbabwe.
Int J Womens Health 9:353–357. 2017;
27. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia.
Lancet 365:785–799. 2005;
28. Howson CP, Kinney MV, McDougall L, Lawn JE. Born Too Soon Preterm Birth Action Group. Born too soon: preterm birth matters.
Reprod Health 10:Suppl 1. S12013;
29. Lee AC, Kozuki N, Cousens S, et al. Estimates of burden and consequences of infants born small for gestational age in low and middle income countries with INTERGROWTH-21
st standard: analysis of CHERG datasets.
BMJ 358:j36772017;
30. Kiserud T, Benachi A, Hecher K, et al. The World Health Organization fetal growth charts: concept, findings, interpretation, and application.
Am J Obstet Gynecol 218:S619–S629. 2018;
31. Al-Turki HA, Abu-Heija AT, Al-Sibai MH. The outcome of pregnancy in elderly primigravidas.
Saudi Med J 24:1230–1233. 2003;
32. Wall-Wieler E, Roos LL, Nickel NC. Adolescent pregnancy outcomes among sisters and mothers: a population-based retrospective cohort study using linkable administrative data.
Public Health Rep 133:100–108. 2018;
33. Inker LA, Schmid CH, Tighiouart H, et al. CKD-EPI Investigators. Estimating glomerular filtration rate from serum creatinine and cystatin C.
N Engl J Med 367:20–29. 2012;
34. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med 150:604–612. 2009;
35. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.
Ann Intern Med 145:247–254. 2006;
37. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine.
Nephron 16:31–41. 1976;
38. Mundt LA, Shanahan K. Chemical analysis of urine. In: Mundt LA, Shanahan K, Graff’s Textbook of Routine Urinalysis and Body Fluids. 2nd edition. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins Health; p. 35–54. 2010.
39. Kattah AG, Garovic VD. The management of hypertension in pregnancy.
Adv Chronic Kidney Dis 20:229–239. 2013;
40. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy.
Am J Obstet Gynecol 183:S1–S22. 2000;
41. Padma Y, Aparna VB, Kalpana B, Ritika V, Sudhakar PR. Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study.
Int J Reprod Contracept Obstet Gynecol 2:514–520. 2013;
42. Strevens H, Wide-Swensson D, Grubb A. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate.
Scand J Clin Lab Invest 61:575–580. 2001;
43. Franceschini N, Qiu C, Barrow DA, Williams MA. Cystatin C and preeclampsia: a case control study.
Ren Fail 30:89–95. 2008;
44. Babay Z, Al-Wakeel J, Addar M, et al. Serum cystatin C in pregnant women: reference values, reliable and superior diagnostic accuracy.
Clin Exp Obstet Gynecol 32:175–179. 2005;
45. Novakov Mikic A, Cabarkapa V, Nikolic A, et al. Cystatin C in pre-eclampsia.
J Matern Fetal Neonatal Med 25:961–965. 2012;
46. Bjornstad P, Cherney DZI. Kidney function can predict pregnancy outcomes.
Clin J Am Soc Nephrol 12:1029–1031. 2017;
47. Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages.
Clin J Am Soc Nephrol 5:844–855. 2010;
48. Sturgiss SN, Wilkinson R, Davison JM. Renal reserve during human pregnancy.
Am J Physiol 271(1 Pt 2):F16–F20. 1996;
49. Nevis IF, Reitsma A, Dominic A, et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review.
Clin J Am Soc Nephrol 6:2587–2598. 2011;
50. Piccoli GB, Cabiddu G, Attini R, et al. Risk of adverse pregnancy outcomes in women with CKD.
J Am Soc Nephrol 26:2011–2022. 2015;
51. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.
Kidney Int 65:1416–1421. 2004;
52. Chu SC, Wang CP, Chang YH, et al. Increased cystatin C serum concentrations in patients with hepatic diseases of various severities.
Clin Chim Acta 341:133–138. 2004;
53. Fricker M, Wiesli P, Brändle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C.
Kidney Int 63:1944–1947. 2003;
54. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function.
Clin Chim Acta 338:87–90. 2003;
55. Tan GD, Lewis AV, James TJ, et al. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance.
Diabetes Care 25:2004–2009. 2002;
56. Xia LH, Bing XG, An XT. Serum cystatin C assay for the detection of early renal impairment in diabetic patients.
J Clin Lab Anal 18:31–35. 2004;
57. O’Riordan SE, Webb MC, Stowe HJ, et al. Cystatin C improves the detection of mild renal dysfunction in older patients.
Ann Clin Biochem 40:648–655. 2003;
58. Curhan G. Cystatin C: a marker of renal function or something more?
Clin Chem 51:293–294. 2005;
59. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.
Clin Chem 51:321–327. 2005;